Randomized Controlled Trial of Stress Management Training in HIV (SWISSIT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00436085
Recruitment Status : Completed
First Posted : February 16, 2007
Last Update Posted : February 16, 2007
Swiss National Science Foundation
Information provided by:
University of Zurich

February 15, 2007
February 16, 2007
February 16, 2007
December 2003
Not Provided
  • CD4 cell count
  • HIV viral load
Same as current
No Changes Posted
  • Depression and Anxiety
  • QUality of life
Same as current
Not Provided
Not Provided
Randomized Controlled Trial of Stress Management Training in HIV
Randomized Controlled Trial of Stress Management Training in Individuals With HIV Infection
The introduction of highly active antiretroviral therapy (HAART) has dramatically changed the consequences of an HIV infection, which is now viewed as a chronic disease. As in other chronic diseases, emotional distress and depressive symptoms are highly prevalent in HIV-infected patients. Psychological factors such as these have been associated with lower quality of life, lower adherence to therapy and also with a higher risk for mortality and disease progression. Psychosocial interventions, such as group-based cognitive behavioral stress management (CBSM) training, have been shown to reduce distress and psychological symptoms in HIV-infected patients. These psychosocial effects are paralleled by changes in physiological parameters, such as cortisol, DHEA-S, testosterones, catecholamines, and naïve T-cell counts. While these results are congruent with recent evidence of the interaction between psychological, neuroendocrine and immunological parameters in HIV-infected patients, it needs to be shown whether the reported effects hold true in the HAART era. Most importantly, it also needs to be ascertained whether these interventions have an impact on immunological and virological HIV parameters as well as on mortality and morbidity in HIV patients. We propose a randomized controlled one-year prospective evaluation of a group-based CBSM training in 80 HIV-infected patients. Participating patients will be recruited at cooperating centers of the Swiss HIV Cohort Study and randomly assigned to CBSM training or waiting control group condition. At baseline, post-training and two follow-up (6 and 12 months) assessments, effects of the CBSM on psychological, physiological and clinical out-come variables in HIV-infected patients under HAART will be evaluated. Additionally, the effects of CBSM on the neuroendocrine and autonomic stress reactivity in HIV-infected patients will be assessed, thus evaluating a possible direct pathway between emotional distress and physiological HIV-relevant parameters. In conclusion, the planned research project evaluates the effectiveness of a standardized psychosocial intervention as a possible component of a comprehensive disease management in HIV-infected patients under HAART.
Not Provided
Phase 3
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
HIV Infections
Behavioral: Cognitive behavioral stress management training
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
Same as current
December 2005
Not Provided

Inclusion Criteria:

  • Adults between 18 and 65 years of age
  • Sufficient German-speaking abilities to participate in group therapy
  • cARTwithin the previous three months,
  • CD4 lymphocyte count above 100 cells/mL

Exclusion Criteria:

  • Active opportunistic infection at baseline
  • Formal psychotherapy within the previous three months
  • Intravenous drug users
  • Diagnosable current major psychiatric disorder (bipolar affective disorder, psychotic disorders, major depression with melancholia) and diagnosis of antisocial and borderline personality disorders at baseline
Sexes Eligible for Study: All
18 Years to 65 Years   (Adult)
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
Not Provided
Not Provided
University of Zurich
Swiss National Science Foundation
Principal Investigator: Jens Gaab, PhD Clinical Psychology and PSychotherapy, Institute of Psychology, University of Zürich
Principal Investigator: Rainer Weber, MD University Hospital, Zürich
Principal Investigator: Ulrike Ehlert, PhD Clinical Psychology and Psychotherapy, Institute of Psychology, University of Zurich
University of Zurich
February 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP